Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:1317-1324

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamiya, K.
Right arrow Articles by Kodama, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamiya, K.
Right arrow Articles by Kodama, I.
Related Collections
Right arrow Arrythmias-basic studies

(Circulation. 2001;103:1317.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Short- and Long-Term Effects of Amiodarone on the Two Components of Cardiac Delayed Rectifier K+ Current

Kaichiro Kamiya, MD; Atsushi Nishiyama, MD; Kenji Yasui, MD; Mayumi Hojo, BS; Michael C. Sanguinetti, PhD; Itsuo Kodama, MD

From the Department of Circulation, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan, and the Department of Internal Medicine, University of Utah, Salt Lake City, Utah (M.C.S.).

Correspondence to Dr Kaichiro Kamiya, Department of Circulation, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan. E-mail kamiya{at}riem.nagoya-u.ac.jp

Background—Amiodarone is the most promising drug for the treatment of life-threatening tachyarrhythmias in patients with structural heart disease. The pharmacological effects of amiodarone on cardiac ion channels are complex and may differ for short-term and long-term administration.

Methods and Results—The delayed rectifier K+ current (IK) of ventricular myocytes isolated from rabbit hearts was recorded with the whole-cell voltage-clamp technique. IK was separated into 2 components by use of specific blockers for either IKs (chromanol 293B, 30 µmol/L) or IKr (E-4031, 10 µmol/L). Short-term application of amiodarone caused a concentration-dependent decrease in IKr with an IC50 of 2.8 µmol/L (n=8) but only a minimal reduction in IKs. The short-term effects of amiodarone were also determined in Xenopus oocytes expressing the cloned human channels that conduct IKr and IKs (HERG and KvLQT1/minK). HERG current in oocytes was reduced by amiodarone (IC50=38 µmol/L), whereas KvLQT1/minK current was unaffected by 300 µmol/L amiodarone. To study the effects of long-term drug administration, rabbits were treated for 4 weeks with oral amiodarone (100 mg · kg-1 · d-1) before cell isolation. Long-term administration of amiodarone decreased IK to 55% (n=10) in control rabbits and altered the relative density of IKr and IKs. The majority (92%) of current was IKr. mRNA levels of rabbit ERG,KVLQT1, and minK in left ventricular myocardium did not differ between control and long-term amiodarone.

Conclusions—Amiodarone has differential effects on the 2 components of IK, depending on the application period; short-term treatment inhibits primarily IKr, whereas long-term treatment reduces IKs.


Key Words: amiodarone • potassium • mRNA




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. Wu, S. Rajamani, J. C. Shryock, H. Li, J. Ruskin, C. Antzelevitch, and L. Belardinelli
Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone
Cardiovasc Res, February 1, 2008; 77(3): 481 - 488.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Moro, M. Ferreiro, D. Celestino, E. Medei, M. V. Elizari, and S. Sicouri
In Vitro Effects of Acute Amiodarone and Dronedarone on Epicardial, Endocardial, and M Cells of the Canine Ventricle
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 314 - 321.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
D. Celestino, E. Medei, S. Moro, M. V. Elizari, and S. Sicouri
Acute In Vitro Effects of Dronedarone, an Iodine-Free Derivative, and Amiodarone, on the Rabbit Sinoatrial Node Automaticity: A Comparative Study
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 248 - 257.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
N. Yamashita, T. Kaku, T. Uchino, S. Isomoto, H. Yoshimatsu, and K. Ono
Short- and Long-Term Amiodarone Treatments Regulate Cav3.2 Low-Voltage-Activated T-type Ca2+ Channel through Distinct Mechanisms
Mol. Pharmacol., May 1, 2006; 69(5): 1684 - 1691.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Jost, L. Virag, M. Bitay, J. Takacs, C. Lengyel, P. Biliczki, Z. Nagy, G. Bogats, D. A. Lathrop, J. G. Papp, et al.
Restricting Excessive Cardiac Action Potential and QT Prolongation: A Vital Role for IKs in Human Ventricular Muscle
Circulation, September 6, 2005; 112(10): 1392 - 1399.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Le Bouter, A. El Harchi, C. Marionneau, C. Bellocq, A. Chambellan, T. van Veen, C. Boixel, B. Gavillet, H. Abriel, K. Le Quang, et al.
Long-Term Amiodarone Administration Remodels Expression of Ion Channel Transcripts in the Mouse Heart
Circulation, November 9, 2004; 110(19): 3028 - 3035.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon
Pharmacology of cardiac potassium channels
Cardiovasc Res, April 1, 2004; 62(1): 9 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Brandts, R. Borchard, R. Macianskiene, V. Gendviliene, D. Dirkmann, M. Van Bracht, M. Prull, M. Meine, I. Wickenbrock, K. Mubagwa, et al.
Inhibition of G Protein-Coupled and ATP-Sensitive Potassium Currents by 2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015), an Amiodarone Derivative
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 134 - 142.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Kirchhof, H. Degen, M. R. Franz, L. Eckardt, L. Fabritz, P. Milberg, S. Laer, J. Neumann, G. Breithardt, and W. Haverkamp
Amiodarone-Induced Postrepolarization Refractoriness Suppresses Induction of Ventricular Fibrillation
J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 257 - 263.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
J. Huang, J. L. Skinner, J. M. Rogers, W. M. Smith, W. L. Holman, and R. E. Ideker
The effects of acute and chronic amiodarone on activation patterns and defibrillation threshold during ventricular fibrillation in dogs
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 375 - 383.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Lu, K. Kamiya, T. Opthof, K. Yasui, and I. Kodama
Density and Kinetics of IKr and IKs in Guinea Pig and Rabbit Ventricular Myocytes Explain Different Efficacy of IKs Blockade at High Heart Rate in Guinea Pig and Rabbit: Implications for Arrhythmogenesis in Humans
Circulation, August 21, 2001; 104(8): 951 - 956.
[Abstract] [Full Text] [PDF]